Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 3
- Opioid Abuse (Disorder)
- Clinical Decision Support
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- Yale University
- Enrolment target
- 100
- Started
- 17 August 2026
- Main results due
- February 2027
- Study sites
- 3
- Registry updated
- 25 September 2026
Can you take part?
- Aged 18 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * Emergency department patient * 18 years of age or older * Moderate to severe opioid use disorder Exclusion Criteria: * Under 18 years of age * Pregnant * Currently receiving medication for opioid use disorder
What this study is about
In the sponsor’s own words, from the registry.
This study is stage 2, round 3 of a larger study which refines and optimizes the EMBED clinical decision support (CDS) to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder. See NCT03658642
Study sites(3)
Yale New Haven Shoreline Medical Center
Guilford, Connecticut, United States
Recruiting
Yale New Haven Hospital- St. Raphael
New Haven, Connecticut, United States
Recruiting
Yale New Haven Hospital
New Haven, Connecticut, United States
Recruiting
Showing 3 of 3 sites. 3 of the 3 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07793383. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me